Acute toxicity of silver and carbon nanoaerosols to normal and cystic fibrosis human bronchial epithelial cells

Nanotoxicology

Volumn 10, Issue 3, 2016, Pages 279-291

  Jeannet, Natalie ^a   Fierz, Martin ^b   Schneider, Sarah ^a   Künzi, Lisa ^a   Baumlin, Nathalie ^c   Salathe, Matthias ^c   Burtscher, Heinz ^b   Geiser, Marianne ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Air'liquid interface; airways; cell death; NACIVT; pro inflammatory cytokines

Indexed keywords

CARBON NANOPARTICLE; CASPASE 3; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SILVER NANOPARTICLE; AEROSOL; AUTACOID; CARBON; NANOPARTICLE; PARTICULATE MATTER; SILVER;

ACUTE TOXICITY; AEROSOL; AIR POLLUTION; ARTICLE; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CILIATED EPITHELIUM; DOSE RESPONSE; ENZYME ACTIVITY; EPITHELIAL LINING FLUID; HUMAN; HUMAN CELL; LUNG FIBROSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; CELL PROLIFERATION; CHEMISTRY; CYSTIC FIBROSIS; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PARTICULATE MATTER; PATHOLOGY; PHYSIOLOGY; RESPIRATORY MUCOSA; TOXICITY;

AEROSOLS; CARBON; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; NANOPARTICLES; PARTICULATE MATTER; RESPIRATORY MUCOSA; SILVER;

EID: 84959268343     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2015.1049233     Document Type: Article

References (80)

1. Abu-El-Haija M, Sinkora M, Meyerholz DK, Welsh MJ, Mccray Jr. PB, Butler J, et al. 2011. An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis. Pancreatology 11:506-15
2. Adcock IM, Tsaprouni L, Bhavsar P, Ito K. 2007. Epigenetic regulation of airway inflammation. Curr Opin Immunol 19:694-700
3. Anjilvel S, Asgharian B. 1995. A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 28:41-50
4. Antonsson A, Persson JL. 2009. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities. Anticancer Res 29:2893-8
5. Asharani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-90
6. Baisch BL, Corson NM, Wade-Mercer P, Gelein R, Kennell AJ, Oberdorster G, et al. 2014. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol 11:5
7. Barlow PG, Clouter-Baker A, Donaldson K, Maccallum J, Stone V. 2005. Carbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages. Part Fibre Toxicol 2:11
8. Bitterle E, Karg E, Schroeppel A, Kreyling WG, Tippe A, Ferron GA, et al. 2006. Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 65:1784-90
9. Bok S, Lubguban AA, Gao Y, Bhattacharya S, Korampally V, Hossain M, et al. 2008. Electrochemical properties of carbon nanoparticles entrapped in silica matrix. J Electrochem Soc 155:K91-5
10. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152:2111-18
11. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1-12
12. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. 2002. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165: 904-10
13. Derichs N, Jin BJ, Song Y, Finkbeiner WE, Verkman AS. 2011. Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching. FASEB J 25:2325-32
14. Devalia JL, Campbell AM, Sapsford RJ, Rusznak C, Quint D, Godard P, et al. 1993. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 9:271-8
15. Donaldson K, Stone V, Clouter A, Renwick L, Macnee W. 2001. Ultrafine particles. Occup Environ Med 58:211-16
16. Downey DG, Bell SC, Elborn JS. 2009. Neutrophils in cystic fibrosis. Thorax 64:81-8
17. Edwards-Jones V. 2009. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 49:147-52
18. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, et al. 2001. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol Med 7:523-34
19. Elizur A, Cannon CL, Ferkol TW. 2008. Airway inflammation in cystic fibrosis. Chest 133:489-95
20. Foldbjerg R, Dang DA, Autrup H. 2010. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line A549. Arch Toxicol 85:743-50
21. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. 2005. Well-differentiated human airway epithelial cell cultures. Methods Mol Med 107:183-206
22. Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2
23. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. 2014. Sizedependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol 11:11
24. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. 2004. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med 169:816-21
25. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M. 2011. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7:347-54
26. Han X, Corson N, Wade-Mercer P, Gelein R, Jiang J, Sahu M, et al. 2012. Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology 297:1-9
27. Herzog F, Clift MJ, Piccapietra F, Behra R, Schmid O, Petri-Fink A, et al. 2013. Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface. Part Fibre Toxicol 10:11
28. Hyun JS, Lee BS, Ryu HY, Sung JH, Chung KH, Yu IJ. 2008. Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol Lett 182:24-8
29. Isaacson CW, Kleber M, Field JA. 2009. Quantitative analysis of fullerene nanomaterials in environmental systems: a critical review. Environ Sci Technol 43:6463-74
30. Jeannet N, Fierz M, Kalberer M, Burtscher H, Geiser M. 2015. Nano aerosol chamber for in-vitro toxicity (NACIVT) studies. Nanotoxicology 9:34-42
31. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, et al. 2007. Twentyeight-day inhalation toxicity study of silver nanoparticles in spraguedawley rats. Inhal Toxicol 19:857-71
32. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Davies RJ. 1995. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J 8:1451-7
33. Kim JK, Kang MG, Cho HW, Han JH, Chung YH, Rim KT, et al. 2011a. Effect of nano-sized carbon black particles on lung and circulatory system by inhalation exposure in rats. Saf Health Work 2:282-9
34. Kim JS, Sung JH, Ji JH, Song KS, Lee JH, Kang CS, et al. 2011b. In vivo genotoxicity of silver nanoparticles after 90-day silver nanoparticle inhalation exposure. Saf Health Work 2:34-8
35. Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW. 2012. Sizedependent cellular toxicity of silver nanoparticles. J Biomed Mater Res A 100:1033-43
36. Kim YM, Reed W, Lenz AG, Jaspers I, Silbajoris R, Nick HS, et al. 2005. Ultrafine carbon particles induce interleukin-8 gene transcription and p38 MAPK activation in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 288:L432-41
37. Kreyling WG, Semmler-Behnke M, Moller W. 2006. Ultrafine particlelung interactions: does size matter? J Aerosol Med 19:74-83
38. Kreyling WG, Semmler-Behnke M, Takenaka S, Moller W. 2013. Differences in the biokinetics of inhaled nano-versus micrometersized particles. Acc Chem Res 46:714-22
39. Kumar V, Toffoli G, Rizzolio F. 2013. Fluorescent carbon nanoparticles in medicine for cancer therapy. ACS Med Chem Lett 4:1012-13
40. Kunzelmann K, Schreiber R, Nitschke R, Mall M. 2000. Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator. Pflugers Arch 440:193-201
41. Kunzi L, Mertes P, Schneider S, Jeannet N, Menzi C, Dommen J, et al. 2013. Responses of lung cells to realistic exposure of primary and aged carbonaceous aerosols. Atmosph Environ 68:143-50
42. Lee HY, Park HK, Lee YM, Kim K, Park SB. 2007. A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun (Camb) 2959-61
43. Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. 2011. Silver nanoparticles induce apoptosis and G2/M arrest via PKCzeta-dependent signaling in A549 lung cells. Arch Toxicol 85:1529-40
44. Li XY, Brown D, Smith S, Macnee W, Donaldson K. 1999. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol 11:709-31
45. Lorenz C, Hagendorfer H, von Goetz N, Kaegi R, Gehrig R, Ulrich A, et al. (2011). Nanosized aerosols from consumer sprays: experimental analysis and exposure modeling for four commercial products. J Nanopart Res 13:3377-91
46. Machen TE. 2006. Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 291:C218-30
47. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, et al. 1998. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95:1005-15
48. Mercer RR, Russell ML, Roggli VL, Crapo JD. 1994. Cell number and distribution in human and rat airways. Am J Respir Cell Mol Biol 10: 613-24
49. National Institute for Public Health and the Environment (RIVM). 2002. Multiple Path Particle Dosimetry Model (MPPD v 1.0): a model for human and rat airway particle dosimetry. RIVA Report 650010030, Bilthoven, The Netherlands
50. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
51. Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In vitro 24: 872-8
52. Paur HR, Cassee FR, Teeguarden J, Fissan H, Diabate S, Aufderheide M, et al. 2011. In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung-A dialog between aerosol science and biology. J Aerosol Sci 42:668-92
53. Pope III CA. 2000. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk? Environ Health Perspect 108:713-23
54. Ramanakumar AV, Parent ME, Latreille B, Siemiatycki J. 2008. Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: results from two case-control studies in Montreal. Int J Cancer 122:183-9
55. Randell SH, Fulcher ML, O'neal W, Olsen JC. 2011. Primary epithelial cell models for cystic fibrosis research. Methods Mol Biol 742: 285-310
56. Ratjen F. 2006. What's new in CF airway inflammation: an update. Paediatr Respir Rev 7:S70-2
57. Ribeiro CM, Boucher RC. 2010. Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responses. Proc Am Thorac Soc 7:387-94
58. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-73
59. Rosenfeld M, Gibson RL, Mcnamara S, Emerson J, Burns JL, Castile R, et al. 2001. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32:356-66
60. Roy S, Nicholson DW. 2000. Cross-talk in cell death signaling. J Exp Med 192:21-6
61. Ryan TP. 1997. Modern Regression Methods. New York: John Wiley & Sons
62. Satyavani K, Gurudeeban S, Ramanathan T, Balasubramanian T. 2011. Biomedical potential of silver nanoparticles synthesized from calli cells of Citrullus colocynthis (L.) Schrad J Nanobiotechnol 9:43
63. Sayes CM, Reed KL, Warheit DB. 2007. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163-80
64. Schneider S, Schurch D, Geiser M. 2013. Aspiration toxicology of hydrocarbons and lamp oils studied by in vitro technology. Toxicol In Vitro 27:1089-101
65. Seagrave J, Mcdonald JD, Mauderly JL. 2005. In vitro versus in vivo exposure to combustion emissions. Exp Toxicol Pathol 57:233-8
66. Shi Y, Wang F, He J, Yadav S, Wang H. 2010. Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/ t-Bid-independent mitochondrial pathway. Toxicol Lett 196:21-7
67. Sims DE, Horne MM. 1997. Heterogeneity of the composition and thickness of tracheal mucus in rats. Am J Physiol 273:L1036-41
68. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ, et al. 2010. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2: 29ra31
69. Suliman YA, Ali D, Alarifi S, Harrath AH, Mansour L, Alwasel SH. 2015. Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells. Environ Toxicol 30:149-60
70. Sun X, Sui H, Fisher JT, Yan Z, Liu X, Cho HJ, et al. 2010. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120:3149-60
71. Totlandsdal AI, Refsnes M, Lag M. 2010. Mechanisms involved in ultrafine carbon black-induced release of IL-6 from primary rat epithelial lung cells. Toxicol In Vitro 24:10-20
72. Ulrich M, Herbert S, Berger J, Bellon G, Louis D, Munker G, et al. 1998. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence. Am J Respir Cell Mol Biol 19:83-91
73. Van Goor F, Straley KS, Cao D, Gonzalez J, Hadida S, Hazlewood A, et al. 2006. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol 290:L1117-30
74. Van Nieuwenhuijze AEM, Van Lopik T, Smeenk RJT, Aarden LA. 2003. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. Ann Rheumatic Dis 62:10-14
75. Welch BL. 1938. The significance of the difference between two means when the population variances are unequal. Biometrika 29: 350-62
76. Welch BL. 1947. The generalization of students problem when several different population variances are involved. Biometrika 34: 28-35
77. Welsh MJ, Smith AE. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-4
78. Woodrow Wilson International Center for Scholars. The project on emerging nanotechnologies (PEN). Available at: http://nanotechproject. org/cpi/. Accessed on 6 August 2014
79. Zhang YY, Sun J. 2007. A study on the bio-safety for nano-silver as antibacterial materials. Zhongguo Yi Liao Qi Xie Za Zhi 31:36-8
80. Zimmer AT, Baron PA, Biswas P. 2002. The influence of operating parameters on number-weighted aerosol size distribution generated from a gas metal arc welding process. J Aerosol Sci 33:519-31.